Daniel Shames's Insider Trades & SAST Disclosures
Daniel Shames's most recent trade in Mereo Biopharma Group Plc - ADR was a trade of 55,000 Share Options (Right to buy) done . Disclosure was reported to the exchange on Feb. 5, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Daniel Shames.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mereo Biopharma Group Plc ... | Daniel Shames | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 55,000 | 55,000 | - | - | Share Options (Right to buy) | |
| Mereo Biopharma Group Plc ... | Daniel Shames | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 13,719 | 13,719 | - | - | Deferred Restricted Stock Units | |
| Mereo Biopharma Group Plc ... | Daniel Shames | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 45,000 | 45,000 | - | - | Share Options (Right to buy) | |
| Mereo Biopharma Group Plc ... | Shames Daniel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 14,139 | 14,139 | - | - | Deferred Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges